ENDEAVOR PHARMACEUTICALS
Endeavor Pharmaceuticals is a specialty pharmaceutical company initially focused on improving women's health by developing and marketing advanced hormone therapies with competitive advantages over existing therapies. The company's headquarters are located in North Carolina and its marketing and sales office is located in New Jersey.
ENDEAVOR PHARMACEUTICALS
Industry:
Biotechnology
Founded:
1994-01-01
Address:
Wilmington, North Carolina, United States
Country:
United States
Website Url:
http://www.endeavorpharm.com
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Amazon AWS Global Accelerator
Similar Organizations
Jeil Pharmaceutical
Jeil Pharmaceutical is a contributed to the growth and development of the pharmaceutical industry.
Women's International Pharmacy
Women's International Pharmacy is a pharmaceutical company offering bioidentical hormone replacement therapy services.
Official Site Inspections
http://www.endeavorpharm.com
Unable to get host informations!!!
More informations about "Endeavor Pharmaceuticals"
Endeavor Pharmaceuticals - Crunchbase Company โฆ
Contact Email [email protected] Endeavor Pharmaceuticals is a specialty pharmaceutical company initially focused on improving women's โฆSee details»
Endeavor Pharmaceuticals Inc - Company Profile and News
Company profile page for Endeavor Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Endeavor Pharmaceuticals Company Profile | Management and
Endeavor Pharmaceuticals Profile and History . Endeavor Pharmaceuticals, a privately held company with headquarters in Wilmington, North Carolina, is a specialty pharmaceutical โฆSee details»
Endeavor Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
North Carolina, United States | endeavorpharm.com. Last update 19 Sep 2024See details»
About Us - Endeavor BioMedicines
A Culture of Going Beyond We believe in pushing the boundaries of medical innovation to create new therapeutic possibilities for patients. We have created a supportive and inspiring company culture that empowers individuals and โฆSee details»
Endeavor Pharmaceuticals, Inc. | VentureRadar
Ardena Belgium n/a Ardena is a fully integrated Contract Development & Manufacturing Organization (CDMO) with a core focus on bringing molecules to the clinics. AGTC โฆSee details»
Our Leadership Team - Endeavor BioMedicines
Prior to joining Endeavor BioMedicines, she was the Head of Human Resources at Evofem Biosciences, Inc., where she served as a part of the executive management team leading all the human resources functions of the โฆSee details»
Endeavor Pharmaceuticals Financial Overview, Employee Count, โฆ
Endeavorpharm.com. Endeavor Pharmaceuticals. Founded in 1994 +1(910) 790-9811. Wilmington, North Carolina. Endeavor Pharmaceuticals' financial review. Endeavor โฆSee details»
Endeavor Pharmaceuticals | Company | RadialReport
Endeavor Pharmaceuticals is a specialty pharmaceutical company initially focused on improving women's health by developing and marketing advanced hormone therapies with competitive โฆSee details»
Clinical-stage Biotechnology Company | Endeavor โฆ
Endeavor BioMedicines is a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases. Endeavorโs lead investigational candidate, ENV โฆSee details»
Endeavor completes its Phase 2a trial of ENV-101 for IPF
The Phase 2a trial (NCT04968574) assessed the effects of about three months of daily ENV-101 treatment against a placebo in 41 adults with IPF. The first patient was dosed in 2021, and the โฆSee details»
Endeavor raises $101m in Series B round to progress treatment โฆ
Feb 8, 2022 ENV-201 is a small molecule ULK1/2 inhibitor to treat KRAS-driven cancers. The clinical-stage biotechnology company anticipates concluding investigational new drug (IND) โฆSee details»
Endeavor BioMedicines Raises $132.5 Million Oversubscribed โฆ
SAN DIEGO, April 24, 2024--Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational โฆSee details»
Endeavor pulls in $132M to back cancer, lung disease drugs
Apr 24, 2024 Preliminary Phase 2 study results suggested the drug may improve on standard therapies that can only slow the decline of lung function. The company will use the new funds โฆSee details»
Fibrosis-focused Endeavor bags $132.5M series C - Fierce Biotech
Apr 24, 2024 Endeavor bags $132.5M series C, extending runway through 2026See details»
Endeavor BioMedicines Successfully Completes Phase 2a Trial of โฆ
SAN DIEGO, January 24, 2024--Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients โฆSee details»
Instructions For Use - EndeavorOTC
1 Stamatis, C. A., Mercaldi, C., & Kollins, S. H. (2023). A Single-Arm Pivotal Trial to Assess the Efficacy of Akl-T01, a Novel Digital Intervention for Attention, in Adults Diagnosed With ADHD. โฆSee details»
Top News | Endeavor BioMedicines
Jan 24, 2024 Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines โ Proceeds will support clinical โฆSee details»
Endeavor Health Achieves Prestigious Magnet® Redesignation for โฆ
3 days ago Endeavor Health's Elmhurst, Northwest Community and Swedish Hospitals are in the early stages of applying for Magnet redesignation, with results anticipated in 2025. This โฆSee details»
EndeavorRx® - ADHD Video Game Treatment for Kids | FDA โฆ
EndeavorRx: Indications, Safety and Cautions. Indications: EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children โฆSee details»